Home » Topics » BioWorld Science

BioWorld Science
RSS

UCARTMESO, MSLN-targeting allogeneic CAR T cells with preclinical efficacy against solid tumors

Nov. 15, 2021

PA-001 for COVID-19 completes preclinical testing

Nov. 15, 2021

BACE1 inhibition may find new target in glioblastoma

Nov. 15, 2021

First preclinical results of AB-201, a novel allogeneic anti-HER2 CAR NK-cell therapy

Nov. 15, 2021

M-6223 induces antitumor immune response through multiple mechanisms of action

Nov. 15, 2021

Assembly Biosciences synthesizes new HBV antivirals

Nov. 15, 2021

Janssen Pharmaceutica identifies NLRP3 inflammasome inhibitors

Nov. 15, 2021

Tenova Pharmaceuticals discloses EGFR and/or ALK inhibitors

Nov. 15, 2021

Heptares Therapeutics patents histamine H4 receptor antagonists

Nov. 15, 2021

Jmackem divulges new TRPV1 antagonists

Nov. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...